Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies

Efficacy of PPV23 in Preventing Pneumococcal Pneumonia in Adults at Increased Risk – A Systematic Review and Meta-Analysis

(2016) Julia Schiffner-Rohe et al.   PLoS One

Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against Invasive Disease and Hospital-Treated Pneumonia Among People Aged ≥65 Years: A Retrospective Case-Control Study

(2015) Maya Leventer-Roberts et al.   CLINICAL INFECTIOUS DISEASES

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

(2015) Matthew R Moore et al.   LANCET INFECTIOUS DISEASES

Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults

(2015) Marc J.M. Bonten et al.   NEW ENGLAND JOURNAL OF MEDICINE

The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old—Taiwan's PPV vaccination program

(2015) Ying-Huang Tsai et al.   VACCINE

Conducting Meta-Analyses inRwith themetaforPackage

(2015) Wolfgang Viechtbauer   Journal of Statistical Software

Prospective Cohort Study on the Effectiveness of Influenza and Pneumococcal Vaccines in Preventing Pneumonia Development and Hospitalization

(2014) Joon Young Song et al.   Clinical and Vaccine Immunology

Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine Against Community-Acquired Pneumonia in the General Population Aged >=60 Years: 3 Years of Follow-up in the CAPAMIS Study

(2014) O. Ochoa-Gondar et al.   CLINICAL INFECTIOUS DISEASES

Use of vaccines as probes to define disease burden

(2014) Daniel R Feikin et al.   LANCET

The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: Results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study

(2014) Timothy L. Wiemken et al.   VACCINE

Effectiveness of Influenza Vaccination in Institutionalized Older Adults: A Systematic Review

(2013) Tuen-Ching Chan et al.   Journal of the American Medical Directors Association

Evaluating the clinical effectiveness of pneumococcal vaccination in preventing myocardial infarction: The CAPAMIS study, three-year follow-up

(2013) O. Ochoa-Gondar et al.   VACCINE

Long-term Comparative Immunogenicity of Protein Conjugate and Free Polysaccharide Pneumococcal Vaccines in Chronic Obstructive Pulmonary Disease

(2012) Mark T. Dransfield et al.   CLINICAL INFECTIOUS DISEASES

Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells

(2012) Elizabeth A. Clutterbuck et al.   JOURNAL OF INFECTIOUS DISEASES

Clinical effectiveness of pneumococcal polysaccharide vaccine in men: California Men's Health Study

(2012) Rulin C. Hechter et al.   VACCINE

Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in patients with chronic pulmonary diseases

(2012) Angel Vila-Corcoles et al.   Human Vaccines & Immunotherapeutics

Prevention of Acute Myocardial Infarction and Stroke among Elderly Persons by Dual Pneumococcal and Influenza Vaccination: A Prospective Cohort Study

(2010) Ivan F. N. Hung et al.   CLINICAL INFECTIOUS DISEASES

Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly

(2010) A. Dominguez et al.   EUROPEAN RESPIRATORY JOURNAL

Clinical and economic burden of community-acquired pneumonia among adults in Europe

(2010) T Welte et al.   THORAX

Efficacy of pneumococcal vaccination in adults: a meta-analysis

(2009) A. Huss et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: A matched case–control study

(2009) Angel Vila-Corcoles et al.   VACCINE

Effectiveness of pneumococcal vaccination in older adults with chronic respiratory diseases: Results of the EVAN-65 study

(2008) Olga Ochoa-Gondar et al.   VACCINE

Effectiveness of 23-valent polysaccharide pneumococcal vaccine on pneumonia in HIV-infected adults in the United States, 1998–2003

(2008) Eyasu H. Teshale et al.   VACCINE